Abstract
Background
Due to the challenging nature of the type III sphincter of the Oddi dysfunction (SOD) patient, the suspected low diagnostic yield from endoscopic retrograde cholangiopancreatography (ERCP), the high complication rate, and the potential for litigation it is surprising that diagnostic ERCP continues to be performed in this patient population.
Aims
The purpose of this study was to determine the incidence of significant findings on ERCP alone in patients with disabling abdominal pain of suspected pancreatobiliary origin and no objective findings.
Methods
Entry criteria of this study included: (1) ERCP with attempt at visualization of both the biliary tree and pancreatic duct, (2) suspected of having abdominal pain of pancreatobiliary origin, (3) biliary or pancreatic type III by the modified Geenen–Hogan classification, (4) never undergone sphincterotomy, (5) attempted manometry of both sphincters. A total of 265 patients met entry criteria.
Results
Significant findings were found in seven patients (2.6 %): choledococoele (1), anomalous pancreatobiliary ductal union (2), mild-moderate chronic pancreatitis (2), and pancreatic duct filling defect suspicious for IPMN (2). Potentially significant in 25 patients (9.4 %) were: equivocal chronic pancreatitis (1), incomplete (4) and complete pancreas divisum (20). SOD was diagnosed in 77.7 %. 11.3 % had undergone a previous diagnostic ERCP.
Conclusion
ERCP in this high-risk population requires detailed informed consent, availability of SOM to increase the diagnostic yield, and skills in placing prophylactic pancreatic stents. It is our belief that patients without objective findings of pancreatobiliary disease that would explain their subjective complaints should not undergo diagnostic ERCP.
Similar content being viewed by others
Abbreviations
- ERCP:
-
Endoscopic retrograde cholangiopancreatography
- SOD:
-
Sphincter of Oddi dysfunction
- SOM:
-
Sphincter of Oddi manometry
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- ALP:
-
Alkaline phosphatase
- mm:
-
Millimeters
- CT:
-
Computed tomography scan
- MRCP:
-
Magnetic resonance cholangiopancreotography
- EUS:
-
Endoscopic ultrasound
- ASGE:
-
American Society for Gastrointestinal
- NIH:
-
National Institute of Health
References
Pasricha PJ. There is no role for ERCP in unexplained abdominal pain of pancreatic or biliary origin. Gastrointest Endosc. 2002;56:S267–S272.
NIH. Endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy (Sherman abstract). State-of-the-Science conference, U.S. Department of Health and Human Services, 14–16 January 2002.
Sherman S. What is the role of ERCP in the setting of abdominal pain of pancreatic or biliary origin (suspected sphincter of Oddi dysfunction)? Gastrointest Endosc. 2002;56:S258–S266.
Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62:1–8.
Cotton PB. Analysis of 59 ERCP lawsuits; mainly about indications. Gastrointest Endosc. 2006;63:378–382.
Cohen S, Bacon BR, Berlin JA, et al. National Institutes of Health State-of-the-Science conference statement: ERCP for diagnosis and therapy, January 14–16, 2002. Gastrointest Endosc. 2002;56:803–809.
Sgouros SN, Pereira SP. Systematic review: sphincter of Oddi dysfunction—non-invasive diagnostic methods and long-term outcome after endoscopic sphincterotomy. Aliment Pharmacol Ther. 2006;24:237–246.
Ruddell WS, Lintott DJ, Axon AT. The diagnostic yield of ERCP in the investigation of unexplained abdominal pain. Br J Surg. 1983;70:74–75.
Sherman S, Fogel E, Phillips S, et al. Yield of diagnostic ERCP for pancreatobiliary pain alone—can we justify the procedure? Gastrointest Endosc. 1999;49:84A.
Eversman D, Fogel EL, Rusche M, et al. Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. Gastrointest Endosc. 1999;50:637–641.
Fogel EL, Sherman S, Bucksot L, Lehman GA. Effects of droperidol on the pancreatic and biliary sphincter. Gastrointest Endosc. 2003;58:488–492.
Sherman S, Gottlieb K, Uzer MF, et al. Effects of meperidine on the pancreatic and biliary sphincter. Gastrointest Endosc. 1996;44:239–242.
Freeman ML. Adverse outcomes of endoscopic retrograde cholangiopancreatography: avoidance and management. Gastrointest Endosc Clin N Am. 2003;13:775–798, xi.
Mallery JS, Baron TH, Dominitz JA, et al. Standards of practice committee, American Society for Gastrointestinal Endoscopy: complications of ERCP. Gastrointest Endosc. 2003;57:633–638.
Pereira SP, Gillams A, Sgouros SN, Webster GJM, Hatfield ARW. Long term outcome of patients with sphincter of Oddi dysfunction after endoscopic sphincterotomy; a prospective study. Gut. 2006;55:A60 (abstract).
Pineau BC, Knapple WL, Spicer KM, et al. Cholecystokinin-stimulated mebrofenin (99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: assessment of specificity, interobserver reliability, and reproducibility. Am J Gastroenterol. 2001;l96:3016–3109.
Toouli J. Biliary scintigraphy versus sphincter of Oddi manometry in patients with post-cholecystectomy pain: is it time to disregard the scan. Curr Gastroenterol Rep. 2005;7:154–159.
Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary spincterotomy. N Engl J Med. 1996;335:909–918.
Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96:417–423.
Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48:1–10.
Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425–434.
Cotton PB, et al. Challenges in planning and initiating a randomized clinical study of SOD. Gastrointest Endsoc. 2010;72:986–991.
Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1354–1365.
Freeman ML, Gill M, Overby C, Cen YY. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of Oddi dysfunction. J Clin Gastroenterol. 2007;41:94–102.
Conflict of interest
None of the contributing authors have any disclosures related to this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imler, T.D., Sherman, S., McHenry, L. et al. Low Yield of Significant Findings on Endoscopic Retrograde Cholangiopancreatography in Patients with Pancreatobiliary Pain and No Objective Findings. Dig Dis Sci 57, 3252–3257 (2012). https://doi.org/10.1007/s10620-012-2250-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-012-2250-0